Amylyx Pharmaceuticals, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Amylyx Pharmaceuticals, Inc. (AMLX) is 3.47B

According to Amylyx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.47B. This represents a change of 164.76% compared to the average of 1.31B of the last 4 quarters.

Amylyx Pharmaceuticals, Inc. (AMLX) Historical Enterprise Value (quarterly & annually)

How has AMLX Enterprise Value performed in the past?

The mean historical Enterprise Value of Amylyx Pharmaceuticals, Inc. over the last ten years is 1.05B. The current 3.47B Enterprise Value has changed 229.45% with respect to the historical average. Over the past ten years (40 quarters), AMLX's Enterprise Value was at its highest in in the December 2022 quarter at 2.36B. The Enterprise Value was at its lowest in in the December 2020 quarter at 0.

Amylyx Pharmaceuticals, Inc. (AMLX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amylyx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amylyx Pharmaceuticals, Inc. (AMLX) Average Enterprise Value

How has AMLX Enterprise Value performed in the past?

The current Enterprise Value of Amylyx Pharmaceuticals, Inc. (AMLX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Amylyx Pharmaceuticals, Inc. (AMLX) Enterprise Value vs. Peers

How is AMLX’s Enterprise Value compared to its peers?

Amylyx Pharmaceuticals, Inc.’s Enterprise Value is greater than ProMIS Neurosciences, Inc. (-26795232.00), greater than Eledon Pharmaceuticals, Inc. (207.79M), greater than NeuroSense Therapeutics Ltd. (2.23M), greater than Anavex Life Sciences Corp. (-9416480.00), greater than AC Immune S.A. (146.05M), greater than Denali Therapeutics Inc. (2.77B), less than Ionis Pharmaceuticals, Inc. (9.03B), less than Praxis Precision Medicines, Inc. (7.19B), greater than Prothena Corporation plc (135.14M), greater than Clene Inc. (66.54M),

Build a custom stock screener for Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amylyx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amylyx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.